References
- Richter B J, McNutt N S. The spectrum of epidermolysis bullosa acquisita. Arch Dermatol 1979; 115: 1325–8
- Yaoita H, Briggaman R A, Lawley T J, et al. Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol 1981; 76: 288–92
- Gammon W R, Briggaman R A, Woodley D T, et al. Epidermolysis bullosa acquisita—a pemphigoid-like disease. J Am Acad Dermatol 1984; 11: 820–32
- Furue M, Iwata M, Yoon H-I, et al. Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer. J Am Acad Dermatol 1986; 14: 873–8
- Berbis P, Privat Y. Intéret de la colchicine dans le traitement de l'épidermolyse bulleuse acquise. Ann Dermatol Venereol 1989; 116: 301–7
- Nieboer C, Boorsma D M, Woerdeman M J, et al. Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immuno-electron microscopic studies in four patients. Br J Dermatol 1980; 102: 383–92
- Jablonska S, Chorzelski T. When and how to use sulfones in bullous diseases. Int J Dermatol 1981; 20: 103–5
- Rappersberger K, Konrad K, Schenk P, et al. Epidermolysis bullosa acquisita. Eine klinisch-pathologische Studie. Hautarzt 1988; 39: 355–62
- Livden J K, Nilsen R. Acquired epidermolysis bullosa treated with a gold compound. Acta Derm Venereol 1979; 59: 378–9
- Sarret Y. L'épidermolyse bulleuse acquise. Etat actuel des connaissances. Ann Dermatol Venereol 1990; 117: 623–9
- Connolly S M, Sander H M. Treatment of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol 1987; 16: 890, letter
- Zachariae H. Cyclosporine A in epidermolysis bullosa acquisita. J Am Acad Dermatol 1987; 17: 1058–9, letter
- Iannelli P, Bianco M, Catani G, et al. Epidermolisi bollosa acquisita. A proposito di un caso clinico. Giorn It Derm Vener 1988; 123: 29–34
- Crow L L, Finkle J P, Gammon W R, et al. Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol 1988; 19: 937–42
- Gupta A K, Ellis C N, Nickoloff B J, et al. Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol 1990; 126: 339–50
- Layton A M, Cunliffe W J. Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol 1990; 22: 535, letter
- Woodley D T, Crow L. Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol 1990; 22: 535–6, letter
- Merle C, Blanc D, Zultak M, et al. Intractable epidermolysis bullosa acquisita: efficacy of cyclosporin A. Dermatologica 1990; 181: 44–7
- Ho V C, Lui H, McLean D I. Cyclosporine in nonpsoriatic dermatoses. J Am Acad Dermatol 1990; 23: 1248–59
- Gupta A K, Rocher L L, Schmaltz S P, et al. Short-term changes in renal function, blood pressure, and electrolyte levels in patients receiving cyclosporine for dermatologic disorders. Arch Intern Med 1991; 151: 356–62
- Klein J S, Goldin H M, Keegan C, et al. Clear-cell carcinoma of the lung in a patient treated with cyclosporine for epidermolysis bullosa acquisita. J Am A cad Dermatol 1991; 24: 297, letter
- Stewart M I, Woodley D T, Briggaman R A. Epidermolysis bullosa acquisita and associated symptomatic esophageal webs. Arch Dermatol 1991; 127: 373–7
- Mallett R B, Holden C A. Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol 1991; 24: 1034, letter
- Crow L L, Woodley D T. Clearing of epidermolysis bullosa acquisita with cyclosporine. Reply. J Am Acad Dermatol 1991; 24: 1034–5, letter